Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.190
+0.110 (10.19%)
Oct 6, 2025, 4:00 PM EDT
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $3.02 million as of October 6, 2025. Its market cap has decreased by -54.19% in one year.
Market Cap
3.02M
Enterprise Value
13.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.19
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 3.02M, a decrease of -91.16%. That is a compound annual growth rate of -7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 3.02M | -77.79% |
| Dec 31, 2024 | 13.59M | -32.53% |
| Dec 29, 2023 | 20.15M | -62.12% |
| Dec 30, 2022 | 53.19M | -56.27% |
| Dec 31, 2021 | 121.64M | -68.80% |
| Dec 31, 2020 | 389.84M | -9.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |